newsroom header

$5,000,000 Gift to Support Advancing Research about Cancers that Affect Women

Print this pageprint icon

Jul 1, 2014 12:00 PM

July 1, 2014

Huntsman Cancer Institute at the University of Utah
Media Release


Susan Sheehan
Executive Director, Huntsman Cancer Foundation


$5,000,000 Gift to Support Advancing Research about Cancers that Affect Women

Huntsman Cancer Foundation Makes Gift to Expand Efforts in Breast and Gynecologic Cancer Research and Treatment

Huntsman Cancer Foundation President and CEO, David Huntsman, announced today that the Jon M. Huntsman family and Huntsman Cancer Foundation have made another gift in the amount of $5,000,000 to seed the establishment of a Center of Excellence in Women’s Cancers at Huntsman Cancer Institute (HCI). In announcing the gift, Mr. Huntsman stated, “We understand the importance of striking an appropriate balance between investing in buildings and equipment, and also investing in programs and people at Huntsman Cancer Institute. This gift will support the recruitment of top talent in the cancer field to speed discovery from bench to bedside to benefit mothers, wives, sisters, and daughters.”

Mary Beckerle, PhD, CEO and Director of HCI, noted, “HCI is uniquely positioned to discover hidden features of cancer that will be key to eradicating the disease. Our scientists are world leaders in the discovery of inherited susceptibility genes for cancer, including genes responsible for leading cancer killers of women such as breast and ovarian cancer. Just last week, HCI announced the discovery of four new genes that increase familial breast cancer risk.”

Huntsman Cancer Foundation’s sole purpose is to support the lifesaving research taking place at HCI. In addition to seeding the establishment of the Center of Excellence in Women’s Cancers, the foundation raises support each year for cancer research in all areas of cancer, and recently pledged $105 million to construct and equip the new Primary Children’s and Families’ Cancer Research Center at HCI. This 220,000-square-foot expansion will double the research space at the institute, enabling scientists to further understandings about cancer genetics, risk for families and children, and cancer treatment targets, as well as increase clinical trials and create a biotechnology center.

For more information, please visit